Search Results
Search for other papers by Helga Schultz in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Svend Aage Engelholm in
Google Scholar
PubMed
Search for other papers by Eva Harder in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulrik Pedersen-Bjergaard in
Google Scholar
PubMed
Search for other papers by Peter Lommer Kristensen in
Google Scholar
PubMed
-dose glucocorticoid therapy in cancer patients. Thus, only two retrospective studies both hampered by lack of systematic screening and lack of data on the actual screening intensity have reported the incidence in the range from 13% to 37% ( 4 , 5 ). In these studies
Medical College, Shantou University, Shantou, China
Search for other papers by Xiaoyi Qi in
Google Scholar
PubMed
Search for other papers by Liangxian Qiu in
Google Scholar
PubMed
Search for other papers by Shijia Wang in
Google Scholar
PubMed
Search for other papers by Xiongbiao Chen in
Google Scholar
PubMed
Search for other papers by Qianwen Huang in
Google Scholar
PubMed
Medical College, Shantou University, Shantou, China
Search for other papers by Yixuan Zhao in
Google Scholar
PubMed
Search for other papers by Kunfu Ouyang in
Google Scholar
PubMed
Search for other papers by Yanjun Chen in
Google Scholar
PubMed
found no correlation between NTIS and the HF prognosis ( 6 , 7 ), and supporting evidence from large-scale prospective cohort studies is scarce. Therefore, we performed this meta-analysis to explore the association between NTIS and the HF prognosis
AP-HP.Nord-Université de Paris, Hôpital Universitaire Robert Debré, Unité d’Épidémiologie Clinique, Inserm, Paris, France
Search for other papers by Enora Le Roux in
Google Scholar
PubMed
Search for other papers by Florence Menesguen in
Google Scholar
PubMed
Search for other papers by Isabelle Tejedor in
Google Scholar
PubMed
Search for other papers by Marc Popelier in
Google Scholar
PubMed
Search for other papers by Marine Halbron in
Google Scholar
PubMed
Search for other papers by Pauline Faucher in
Google Scholar
PubMed
Search for other papers by Sabine Malivoir in
Google Scholar
PubMed
Search for other papers by Graziella Pinto in
Google Scholar
PubMed
Search for other papers by Juliane Léger in
Google Scholar
PubMed
Search for other papers by Stephane Hatem in
Google Scholar
PubMed
Search for other papers by Michel Polak in
Google Scholar
PubMed
Search for other papers by Christine Poitou in
Google Scholar
PubMed
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
. The specific objective of the present study was to describe the initial cohort of patients and analyse their experience of a transition managed under the new programme based on a case management approach. Materials and methods Patients All
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Sofia Maria Lider Burciulescu in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Monica Livia Gheorghiu in
Google Scholar
PubMed
Search for other papers by Andrei Muresan in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Iuliana Gherlan in
Google Scholar
PubMed
Search for other papers by Attila Patocs in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Corin Badiu in
Google Scholar
PubMed
removed, on the same side or contralateral. In hereditary PHEOs a second tumor may occur in the opposite gland, leaving few options for preserving the adrenal function ( 10 , 12 ). Based mainly on retrospective studies, cortical-sparing adrenal surgery
Search for other papers by Laura van Iersel in
Google Scholar
PubMed
Search for other papers by Sarah C Clement in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by Antoinette Y N Schouten-van Meeteren in
Google Scholar
PubMed
Search for other papers by Annemieke M Boot in
Google Scholar
PubMed
Search for other papers by Hedi L Claahsen-van der Grinten in
Google Scholar
PubMed
Search for other papers by Bernd Granzen in
Google Scholar
PubMed
Search for other papers by K Sen Han in
Google Scholar
PubMed
Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Geert O Janssens in
Google Scholar
PubMed
Search for other papers by Erna M Michiels in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by W Peter Vandertop in
Google Scholar
PubMed
Department of Pediatric Oncology/Hematology, Amsterdam University Medical Center, location VU University Medical Center, Amsterdam, The Netherlands
Search for other papers by Dannis G van Vuurden in
Google Scholar
PubMed
Search for other papers by Hubert N Caron in
Google Scholar
PubMed
Department of Pediatrics, Emma Children’s Hospital, Amsterdam University Medical Center, location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by Leontien C M Kremer in
Google Scholar
PubMed
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
chart of retrospective study cohort. ACTHD, adrenocorticotropic hormone deficiency; CBTS, childhood brain tumor survivors; cRT, cranial radiotherapy; FT4, free thyroxine; FU, follow-up time after diagnosis; GHD, growth hormone deficiency; HPD
Search for other papers by Luchuan Li in
Google Scholar
PubMed
Search for other papers by Baoyuan Li in
Google Scholar
PubMed
Search for other papers by Bin Lv in
Google Scholar
PubMed
Search for other papers by Weili Liang in
Google Scholar
PubMed
Search for other papers by Binbin Zhang in
Google Scholar
PubMed
Search for other papers by Qingdong Zeng in
Google Scholar
PubMed
Search for other papers by Andrew G Turner in
Google Scholar
PubMed
Search for other papers by Lei Sheng in
Google Scholar
PubMed
decision-making. The primary aim of this retrospective study was to explore risk factors for malignancy among a cohort of 318 patients with PHPT, with or without benign or malignant thyroid nodules, presenting to two tertiary medical centers in China
Department of Endocrinology, Austin Health, Melbourne, Australia
Division of Endocrinology, Diabetes and Metabolism, Northwell, Great Neck, New York, USA
Search for other papers by Yee-Ming M Cheung in
Google Scholar
PubMed
Search for other papers by Rudolf Hoermann in
Google Scholar
PubMed
Search for other papers by Karen Van in
Google Scholar
PubMed
Search for other papers by Damian Wu in
Google Scholar
PubMed
Search for other papers by Jenny Healy in
Google Scholar
PubMed
Search for other papers by Bella Halim in
Google Scholar
PubMed
Search for other papers by Manjri Raval in
Google Scholar
PubMed
Search for other papers by Maria McGill in
Google Scholar
PubMed
Department of Cardiology, Austin Health, Melbourne Australia
Search for other papers by Ali Al-Fiadh in
Google Scholar
PubMed
Search for other papers by Michael Chao in
Google Scholar
PubMed
Search for other papers by Shane White in
Google Scholar
PubMed
Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia
Search for other papers by Belinda Yeo in
Google Scholar
PubMed
Department of Endocrinology, Austin Health, Melbourne, Australia
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Department of Endocrinology, Austin Health, Melbourne, Australia
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
, 13 , 14 ), with some suggesting an increase in CVD mortality in individuals undergoing AI treatment when compared to either tamoxifen, a selective oestrogen receptor modulator, or placebo ( 10 , 12 , 13 ). However, most studies were retrospective
Search for other papers by Kristin Viste in
Google Scholar
PubMed
Hormone Laboratory, Department of Medicine, Department of Clinical Science, Department of Radiology, Haukeland University Hospital, 5021 Bergen, Norway
Search for other papers by Marianne A Grytaas in
Google Scholar
PubMed
Search for other papers by Melissa D Jørstad in
Google Scholar
PubMed
Search for other papers by Dag E Jøssang in
Google Scholar
PubMed
Search for other papers by Eivind N Høyden in
Google Scholar
PubMed
Search for other papers by Solveig S Fotland in
Google Scholar
PubMed
Search for other papers by Dag K Jensen in
Google Scholar
PubMed
Hormone Laboratory, Department of Medicine, Department of Clinical Science, Department of Radiology, Haukeland University Hospital, 5021 Bergen, Norway
Search for other papers by Kristian Løvås in
Google Scholar
PubMed
Search for other papers by Hrafnkell Thordarson in
Google Scholar
PubMed
Search for other papers by Bjørg Almås in
Google Scholar
PubMed
Hormone Laboratory, Department of Medicine, Department of Clinical Science, Department of Radiology, Haukeland University Hospital, 5021 Bergen, Norway
Search for other papers by Gunnar Mellgren in
Google Scholar
PubMed
studies have shown increased success rate when the sampling procedure was guided by intra-procedural rapid assay measurements of cortisol (17, 18, 19, 20) . A retrospective study has showed that diagnostic centers that introduced such measurements when
Search for other papers by Nella Augusta Greggio in
Google Scholar
PubMed
Search for other papers by Elisa Rossi in
Google Scholar
PubMed
Search for other papers by Silvia Calabria in
Google Scholar
PubMed
Search for other papers by Alice Meneghin in
Google Scholar
PubMed
Search for other papers by Joaquin Gutierrez de Rubalcava in
Google Scholar
PubMed
Search for other papers by Carlo Piccinni in
Google Scholar
PubMed
Search for other papers by Antonella Pedrini in
Google Scholar
PubMed
levothyroxine in terms of dosage, persistence and therapy duration. Methods Data source This historical cohort study was performed using data of CINECA ARNO Observatory, a population-based Italian database ( 30 ). Since 1987, the CINECA ARNO
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Weili Yin in
Google Scholar
PubMed
Search for other papers by Qiuxia Lin in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Yuanna Ling in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Zhen Li in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
amendments or comparable ethical standards. The need for informed consent was waived by the local ethics committee in view of the retrospective nature of the study. Results General characteristics Thirty-one patients (34.8%) met all three